We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.77%
5 Year Est. Return
+48.6%
10 Year Est. Return
–
AUM
$304M
AUM Growth
+$17.2M
Cap. Flow
-$1.31M
Cap. Flow %
-0.43%
Top 10 Hldgs %
39.76%
Holding
80
New
1
Increased
8
Reduced
38
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.66M
2
NVS icon
Novartis
NVS
+$488K
3
GE icon
GE Aerospace
GE
+$177K
4
CVS icon
CVS Health
CVS
+$167K
5
SLB icon
SLB Ltd
SLB
+$90.5K

Top Sells

Rank Stock Value
1
BRKR icon
Bruker
BRKR
+$923K
2
SVU
SUPERVALU Inc.
SVU
+$708K
3
LVLT
Level 3 Communications Inc
LVLT
+$282K
4
DO
Diamond Offshore Drilling
DO
+$261K
5
INTC icon
Intel
INTC
+$140K

Sector Composition

Rank Sector Weight
1 Healthcare 27.94%
2 Industrials 23%
3 Technology 16.75%
4 Energy 9.09%
5 Consumer Staples 8.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCAR icon
1
PACCAR
PCAR
$69.6B
$20.1M 6.62%
424,457
– –
HD icon
2
Home Depot
HD
$332B
$13.5M 4.43%
71,078
– –
AAPL icon
3
Apple
AAPL
$4.89T
$12.9M 4.25%
305,260
-2,020
-0.7% -$84.4K
INTC icon
4
Intel
INTC
$466B
$11.8M 3.87%
254,561
-3,209
-1% -$140K
WBA
5
DELISTED
Walgreens Boots Alliance
WBA
$11.4M 3.74%
156,619
-1,824
-1% -$128K
HUBB icon
6
Hubbell
HUBB
$25.7B
$10.6M 3.49%
78,421
-675
-0.9% -$84.2K
BIIB icon
7
Biogen
BIIB
$29.9B
$10.6M 3.49%
33,260
-162
-0.5% -$52K
JNJ icon
8
Johnson & Johnson
JNJ
$635B
$10M 3.29%
71,567
-718
-1% -$100K
COST icon
9
Costco
COST
$415B
$10M 3.29%
53,718
-48
-0.1% -$8.29K
WWD icon
10
Woodward
WWD
$25B
$9.94M 3.27%
129,862
-1,326
-1% -$104K
ABBV icon
11
AbbVie
ABBV
$458B
$8.14M 2.68%
84,157
-525
-0.6% -$49.5K
DE icon
12
Deere & Co
DE
$170B
$8.11M 2.67%
51,809
-717
-1% -$100K
WAT icon
13
Waters Corp
WAT
$36.8B
$8.11M 2.67%
41,952
– –
MSFT icon
14
Microsoft
MSFT
$2.84T
$7.51M 2.47%
87,821
-500
-0.6% -$41K
PEP icon
15
PepsiCo
PEP
$186B
$6.55M 2.16%
54,665
-250
-0.5% -$28.5K
SLB icon
16
SLB Ltd
SLB
$77.8B
$6.29M 2.07%
93,315
+1,396
+2% +$90.5K
NVS icon
17
Novartis
NVS
$295B
$6.29M 2.07%
83,550
+6,467
+8% +$488K
IBM icon
18
IBM
IBM
$202B
$6.05M 1.99%
41,239
+103
+0.3% +$15K
FLIR
19
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$6M 1.97%
128,643
-1,047
-0.8% -$47.8K
XOM icon
20
ExxonMobil
XOM
$651B
$5.58M 1.84%
66,649
– –
AEGN
21
DELISTED
Aegion Corp
AEGN
$5.5M 1.81%
216,098
-1,762
-0.8% -$44.2K
A icon
22
Agilent Technologies
A
$39.1B
$5.02M 1.65%
74,960
– –
EMR icon
23
Emerson Electric
EMR
$82.9B
$4.79M 1.58%
68,795
-790
-1% -$51.2K
BRKR icon
24
Bruker
BRKR
$9.2B
$4.61M 1.52%
134,447
-28,185
-17% -$923K
CL icon
25
Colgate-Palmolive
CL
$72.6B
$4.59M 1.51%
60,831
-183
-0.3% -$13.4K
1
2 3 4

Similar funds

CFS
Ceros Financial Services Rockville, Maryland $316M AUM
SVWA
Sound View Wealth Advisors Savannah, Georgia $319M AUM
SAS
Sarbit Advisory Services Winnipeg, Manitoba, Canada $294M AUM 0.68% 1-Year Est. Return
LYV
Live Your Vision West Conshohocken, Pennsylvania $330M AUM 2.28% 1-Year Est. Return
TAT
TD Ameritrade Trust Denver, Colorado $285M AUM 0.17% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return
OAMU
Ostrum Asset Management US New York $359M AUM
TCM
Tradition Capital Management Summit, New Jersey $369M AUM 6.72% 1-Year Est. Return

Thompson Rubinstein Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Rubinstein Investment Management held 80 positions worth $304M, up 6% from $287M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 3.8%. Thompson Rubinstein Investment Management opened 1 new position and exited 2, leaving the 80-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management's largest Q4 2017 buy was Celgene Corp: 14,732 shares worth $1.54M.
  • Thompson Rubinstein Investment Management added most to Novartis in Q4 2017, an estimated $488K increase.
  • Thompson Rubinstein Investment Management's biggest Q4 2017 reduction was Bruker, cutting an estimated $923K.
  • Thompson Rubinstein Investment Management fully exited SUPERVALU Inc. in Q4 2017, selling an estimated $708K.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 40% of its $304M portfolio in Q4 2017.
  • Thompson Rubinstein Investment Management opened 1 new position and closed 2 in Q4 2017.
  • Thompson Rubinstein Investment Management's portfolio value rose 6% quarter-over-quarter to $304M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q4 2017, filed 17 Jan 2018.